Among the bargain stocks, Berry says, is Cell Genesys (nasdaq: CEGE - news - people ), which has a number of products in late stage-three trials, including a vaccine for non-small cell lung cancer.
FORBES: Magazine Article
应用推荐
模块上移
模块下移
不移动